This map shows the geographic impact of Bertino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bertino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bertino more than expected).
This network shows the impact of papers produced by Bertino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bertino. The network helps show where Bertino may publish in the future.
Co-authorship network of co-authors of Bertino
This figure shows the co-authorship network connecting the top 25 collaborators of Bertino.
A scholar is included among the top collaborators of Bertino based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Bertino. Bertino is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
María, et al.. (2014). Gut microbiota in alcoholic liver disease: Pathogenetic role and therapeutic perspectives. 世界胃肠病学杂志：英文版（电子版）. 16639–16648.1 indexed citations
2.
Marco, M D, et al.. (2011). L-carnitine supplementation improves hematological pattern in patients affected by HCV treated with Peg interferon-α 2b plus ribavirin. 世界胃肠病学杂志：英文版. 17(39). 4414–4420.1 indexed citations
3.
Wang, Bo Bo, Kong, et al.. (2009). Exposing Copy-Paste-Blur Forgeries Based on Color Coherence. 电子学报：英文版. 18(3). 487–490.1 indexed citations
4.
Adhikari, Debasis Das, et al.. (2001). Pretreatment of endometrial carcinoma cell lines with butyrate results in upregulation of Bax and correlates with potentiation of radiation induced cell kill.. PubMed. 14(5). 603–9.8 indexed citations
5.
Bertino, et al.. (2001). Current understanding of methotrexate pharmacology and efficacy in acute leukemias. Use of newer antifolates in clinical trials.. PubMed. 86(2). 121–7.69 indexed citations
6.
Banerjee, D., H.J. Lenz, Barbara Schnieders, et al.. (1995). Transfection of wild-type but not mutant p53 induces early monocytic differentiation in HL60 cells and increases their sensitivity to stress.. PubMed. 6(11). 1405–13.42 indexed citations
7.
Banerjee, Debabrata, et al.. (1994). Transfection of a nonactive site mutant murine DHFR cDNA (the tryptophan 15 mutant) into Chinese hamster ovary and mouse marrow progenitor cells imparts MTX resistance in vitro.. PubMed. 1(3). 181–4.4 indexed citations
8.
Volkenandt, Matthias, R. Wienecke, Jan Buer, et al.. (1992). Detection of Monoclonal Lymphoid Subpopulations in Clinical Specimens by Pcr and Conformational Polymorphisms of Crna Molecules. Journal of Investigative Dermatology. 98(4). 508–508.4 indexed citations
9.
Bertino, Jing Lin, Tanya Trippett, et al.. (1992). Enzymes of the thymidylate cycle as targets for chemotherapeutic agents: mechanisms of resistance.. PubMed. 59(5). 391–5.6 indexed citations
10.
Bertino, et al.. (1982). Randomized study comparing doxorubicin, cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (ACOMLA) with cyclophosphamide, doxorubicin, vincristine, prednisone, and bleomycin (CHOP-B) in the treatment of diffuse histiocytic lymphoma.. PubMed. 66(6). 1279–84.18 indexed citations
11.
Bertino, et al.. (1981). Possible hazards of working with cytotoxic agents: a review of the literature.. PubMed. 8(4). 10–2.8 indexed citations
12.
Bertino, et al.. (1978). Inhibition of two human tumor cell lines by antimetabolites of coenzyme Q10.. PubMed. 19(3). 485–90.10 indexed citations
13.
Bertino, et al.. (1977). Natural resistance to methotrexate in human acute nonlymphocytic leukemia.. PubMed. 61(4). 667–73.16 indexed citations
14.
Bertino, et al.. (1976). Clinical and pharmacological evaluation of triazinate in humans.. PubMed. 36(1). 48–54.20 indexed citations
15.
Bertino, et al.. (1976). Preclinical studies with triazinate (NSC-139105), an antifolate drug, in beagle dogs and rhesus monkeys.. PubMed. 59(3). 523–30.2 indexed citations
16.
Levitt, Martin, et al.. (1973). Improved therapeutic index of methotrexate with "leucovorin rescue".. PubMed. 33(7). 1729–34.123 indexed citations
17.
Levitt, Martin, et al.. (1970). The Yale combination chemotherapy program for advanced Hodgkin's disease. A preliminary report.. PubMed. 34(12). 862–6.2 indexed citations
18.
Ms, Mitchell, et al.. (1968). Effectiveness of high-dose infusions of methotrexate followed by leucovorin in carcinoma of the head and neck.. PubMed. 28(6). 1088–94.48 indexed citations
19.
Bertino, et al.. (1967). Symposium on immunosuppressive drugs. Folate antagonists: some biochemical and pharmacological considerations.. PubMed. 26(3). 893–7.6 indexed citations
20.
Bertino, et al.. (1964). TECHNIQUES FOR STUDY OF RESISTANCE TO FOLIC ACID ANTAGONISTS.. PubMed. 10. 297–307.52 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.